BIOMAT Database Logo BIOMAT Database Logo

Possible troglitazone-warfarin interaction. 1998

B K Plowman, and A P Morreale

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D002839 Chromans Benzopyrans saturated in the 2 and 3 positions. Dihydrobenzopyrans
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077288 Troglitazone A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity. 5-(4-((6-Hydroxy-2,5,7,8-tetramethylchroman-2-yl-methoxy)benzyl)-2,4-thiazolidinedione) - T,CS 045,CS-045,Prelay,Rezulin,CS045
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

B K Plowman, and A P Morreale
Possible nafcillin-warfarin interaction.
April 1994, Archives of internal medicine,
B K Plowman, and A P Morreale
Possible warfarin-erythromycin interaction.
July 1980, Archives of internal medicine,
B K Plowman, and A P Morreale
Moricizine-warfarin: a possible drug interaction.
January 1992, The Annals of pharmacotherapy,
B K Plowman, and A P Morreale
Possible interaction between warfarin and quetiapine.
August 1999, Journal of clinical psychopharmacology,
B K Plowman, and A P Morreale
Possible antiretroviral therapy-warfarin drug interaction.
July 2008, Pharmacotherapy,
B K Plowman, and A P Morreale
Possible interaction between warfarin and fluconazole.
January 1993, Pharmacotherapy,
B K Plowman, and A P Morreale
Possible interaction between ciprofloxacin and warfarin.
January 1990, DICP : the annals of pharmacotherapy,
B K Plowman, and A P Morreale
Possible interaction of warfarin and stanozolol.
June 1987, Clinical pharmacy,
B K Plowman, and A P Morreale
[Possible interaction between probiotics and warfarin].
January 2010, Lakartidningen,
B K Plowman, and A P Morreale
Possible interaction between gatifloxacin and warfarin.
June 2002, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
Copied contents to your clipboard!